

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.67942386 |
| 2 | drug catabolic process (GO:0042737) | 9.15818164 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.90327487 |
| 4 | negative regulation of fibrinolysis (GO:0051918) | 7.85279765 |
| 5 | regulation of fibrinolysis (GO:0051917) | 7.81987298 |
| 6 | glyoxylate metabolic process (GO:0046487) | 7.79613136 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 7.42407863 |
| 8 | * cellular glucuronidation (GO:0052695) | 7.38242134 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 7.28368408 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.28368408 |
| 11 | * uronic acid metabolic process (GO:0006063) | 7.05623033 |
| 12 | * glucuronate metabolic process (GO:0019585) | 7.05623033 |
| 13 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.73849621 |
| 14 | L-phenylalanine metabolic process (GO:0006558) | 6.73849621 |
| 15 | complement activation, alternative pathway (GO:0006957) | 6.63996553 |
| 16 | regulation of protein activation cascade (GO:2000257) | 6.57114758 |
| 17 | urea metabolic process (GO:0019627) | 6.54866854 |
| 18 | fibrinolysis (GO:0042730) | 6.45462213 |
| 19 | ethanol oxidation (GO:0006069) | 6.33622789 |
| 20 | drug metabolic process (GO:0017144) | 6.15867820 |
| 21 | bile acid biosynthetic process (GO:0006699) | 6.14478416 |
| 22 | oxidative demethylation (GO:0070989) | 6.10425462 |
| 23 | regulation of complement activation (GO:0030449) | 6.09152447 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 5.91257958 |
| 25 | bile acid metabolic process (GO:0008206) | 5.76310059 |
| 26 | phenylpropanoid metabolic process (GO:0009698) | 5.70244597 |
| 27 | aromatic amino acid family catabolic process (GO:0009074) | 5.61010487 |
| 28 | negative regulation of cholesterol transport (GO:0032375) | 5.56850032 |
| 29 | negative regulation of sterol transport (GO:0032372) | 5.56850032 |
| 30 | bile acid and bile salt transport (GO:0015721) | 5.52964580 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.42637980 |
| 32 | protein carboxylation (GO:0018214) | 5.42637980 |
| 33 | blood coagulation, intrinsic pathway (GO:0007597) | 5.41037710 |
| 34 | urea cycle (GO:0000050) | 5.35439320 |
| 35 | regulation of triglyceride catabolic process (GO:0010896) | 5.30754894 |
| 36 | serine family amino acid catabolic process (GO:0009071) | 5.29041676 |
| 37 | ethanol metabolic process (GO:0006067) | 5.13320996 |
| 38 | alkaloid metabolic process (GO:0009820) | 5.02928486 |
| 39 | glycine metabolic process (GO:0006544) | 4.82807902 |
| 40 | negative regulation of blood coagulation (GO:0030195) | 4.79962475 |
| 41 | negative regulation of hemostasis (GO:1900047) | 4.79962475 |
| 42 | amino-acid betaine metabolic process (GO:0006577) | 4.76407912 |
| 43 | regulation of plasminogen activation (GO:0010755) | 4.63449478 |
| 44 | hormone catabolic process (GO:0042447) | 4.61151745 |
| 45 | polyketide metabolic process (GO:0030638) | 4.60868171 |
| 46 | doxorubicin metabolic process (GO:0044598) | 4.60868171 |
| 47 | daunorubicin metabolic process (GO:0044597) | 4.60868171 |
| 48 | S-adenosylmethionine metabolic process (GO:0046500) | 4.56848806 |
| 49 | triglyceride homeostasis (GO:0070328) | 4.53327198 |
| 50 | acylglycerol homeostasis (GO:0055090) | 4.53327198 |
| 51 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.43554103 |
| 52 | negative regulation of coagulation (GO:0050819) | 4.42406907 |
| 53 | heme transport (GO:0015886) | 4.42236411 |
| 54 | phospholipid efflux (GO:0033700) | 4.32416074 |
| 55 | negative regulation of wound healing (GO:0061045) | 4.31917999 |
| 56 | arginine metabolic process (GO:0006525) | 4.31584642 |
| 57 | flavonoid metabolic process (GO:0009812) | 4.30625060 |
| 58 | protein activation cascade (GO:0072376) | 4.27132302 |
| 59 | intestinal cholesterol absorption (GO:0030299) | 4.26452232 |
| 60 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.23741494 |
| 61 | tryptophan catabolic process (GO:0006569) | 4.12247891 |
| 62 | indole-containing compound catabolic process (GO:0042436) | 4.12247891 |
| 63 | indolalkylamine catabolic process (GO:0046218) | 4.12247891 |
| 64 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.11966033 |
| 65 | primary alcohol catabolic process (GO:0034310) | 4.03385489 |
| 66 | serine family amino acid metabolic process (GO:0009069) | 4.00757347 |
| 67 | negative regulation of protein activation cascade (GO:2000258) | 3.99899507 |
| 68 | tyrosine metabolic process (GO:0006570) | 3.97552327 |
| 69 | high-density lipoprotein particle remodeling (GO:0034375) | 3.92361254 |
| 70 | complement activation (GO:0006956) | 3.90460741 |
| 71 | negative regulation of lipase activity (GO:0060192) | 3.85783681 |
| 72 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.85032899 |
| 73 | complement activation, classical pathway (GO:0006958) | 3.84449848 |
| 74 | positive regulation of blood coagulation (GO:0030194) | 3.80202271 |
| 75 | positive regulation of hemostasis (GO:1900048) | 3.80202271 |
| 76 | macromolecular complex remodeling (GO:0034367) | 3.79520907 |
| 77 | plasma lipoprotein particle remodeling (GO:0034369) | 3.79520907 |
| 78 | protein-lipid complex remodeling (GO:0034368) | 3.79520907 |
| 79 | regulation of humoral immune response (GO:0002920) | 3.76946575 |
| 80 | cholesterol efflux (GO:0033344) | 3.76143693 |
| 81 | cellular ketone body metabolic process (GO:0046950) | 3.74412961 |
| 82 | acute-phase response (GO:0006953) | 3.74400353 |
| 83 | * xenobiotic metabolic process (GO:0006805) | 3.74280744 |
| 84 | drug transmembrane transport (GO:0006855) | 3.72266912 |
| 85 | aromatic amino acid family metabolic process (GO:0009072) | 3.71887260 |
| 86 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.68468205 |
| 87 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.68468205 |
| 88 | regulation of cholesterol esterification (GO:0010872) | 3.68392235 |
| 89 | alpha-amino acid catabolic process (GO:1901606) | 3.67562511 |
| 90 | steroid catabolic process (GO:0006706) | 3.63778439 |
| 91 | sodium-independent organic anion transport (GO:0043252) | 3.53212954 |
| 92 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.52028434 |
| 93 | positive regulation of coagulation (GO:0050820) | 3.51034499 |
| 94 | imidazole-containing compound metabolic process (GO:0052803) | 3.50748284 |
| 95 | response to mercury ion (GO:0046689) | 3.49577075 |
| 96 | reverse cholesterol transport (GO:0043691) | 3.46887149 |
| 97 | cysteine metabolic process (GO:0006534) | 3.45640395 |
| 98 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.40886451 |
| 99 | amino acid salvage (GO:0043102) | 3.40115698 |
| 100 | L-methionine biosynthetic process (GO:0071265) | 3.40115698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.42034629 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.35444488 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.01206269 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.09815020 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.96920652 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.11176529 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.83582063 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.50285247 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.47558137 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.29436973 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.19919780 |
| 12 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.14996856 |
| 13 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.12551206 |
| 14 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.02272612 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.83367549 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.71534644 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.67007376 |
| 18 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.56284867 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.55601631 |
| 20 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.52590172 |
| 21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.50997866 |
| 22 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.50578049 |
| 23 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.46050518 |
| 24 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.28379457 |
| 25 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.27809353 |
| 26 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.25116007 |
| 27 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21945956 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19931528 |
| 29 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16653992 |
| 30 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.15979311 |
| 31 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.14752929 |
| 32 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14002646 |
| 33 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.12994425 |
| 34 | AR_20517297_ChIP-Seq_VCAP_Human | 1.11590536 |
| 35 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11091380 |
| 36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.06996903 |
| 37 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.01740530 |
| 38 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.00735781 |
| 39 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.00133949 |
| 40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.00119205 |
| 41 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.98958442 |
| 42 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.98672659 |
| 43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98420758 |
| 44 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.98158614 |
| 45 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.97683645 |
| 46 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.96460142 |
| 47 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.95413886 |
| 48 | CBP_21632823_ChIP-Seq_H3396_Human | 0.93819805 |
| 49 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.93732729 |
| 50 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.91710679 |
| 51 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.90410465 |
| 52 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88968836 |
| 53 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.88688653 |
| 54 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87825237 |
| 55 | NFYA_21822215_ChIP-Seq_K562_Human | 0.87746267 |
| 56 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.87546046 |
| 57 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.86569648 |
| 58 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.86569648 |
| 59 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.85194461 |
| 60 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.85159872 |
| 61 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.84263213 |
| 62 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.84263213 |
| 63 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.83477920 |
| 64 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82255902 |
| 65 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.82185665 |
| 66 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82031012 |
| 67 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.81592882 |
| 68 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.81492877 |
| 69 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.81480200 |
| 70 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.81189654 |
| 71 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81162006 |
| 72 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.80995596 |
| 73 | VDR_22108803_ChIP-Seq_LS180_Human | 0.80476129 |
| 74 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.79175327 |
| 75 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.79082572 |
| 76 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.79082572 |
| 77 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.78961239 |
| 78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.78533080 |
| 79 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.78351659 |
| 80 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.78254422 |
| 81 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.77912162 |
| 82 | NCOR_22424771_ChIP-Seq_293T_Human | 0.77757968 |
| 83 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.77374983 |
| 84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.76669874 |
| 85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.76669874 |
| 86 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.76342224 |
| 87 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.75159303 |
| 88 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.75061074 |
| 89 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.74478452 |
| 90 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.73954209 |
| 91 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.73737284 |
| 92 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.73625492 |
| 93 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.73271259 |
| 94 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.72448726 |
| 95 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.72151242 |
| 96 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.70867764 |
| 97 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.70777121 |
| 98 | STAT3_23295773_ChIP-Seq_U87_Human | 0.70162301 |
| 99 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.69336748 |
| 100 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.68296969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005085_abnormal_gallbladder_physiolo | 6.43790006 |
| 2 | MP0005360_urolithiasis | 6.08261420 |
| 3 | MP0005365_abnormal_bile_salt | 6.07481091 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 5.22019559 |
| 5 | MP0003195_calcinosis | 4.89056227 |
| 6 | MP0002138_abnormal_hepatobiliary_system | 4.36224921 |
| 7 | MP0003252_abnormal_bile_duct | 4.26042651 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.63285714 |
| 9 | MP0003868_abnormal_feces_composition | 3.61864618 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.71958904 |
| 11 | MP0009697_abnormal_copulation | 2.69771616 |
| 12 | MP0002876_abnormal_thyroid_physiology | 2.60401989 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.54841374 |
| 14 | MP0009840_abnormal_foam_cell | 2.41358814 |
| 15 | MP0005332_abnormal_amino_acid | 2.39219800 |
| 16 | MP0002139_abnormal_hepatobiliary_system | 10.0044036 |
| 17 | MP0000609_abnormal_liver_physiology | 1.72618614 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 1.66987857 |
| 19 | MP0001764_abnormal_homeostasis | 1.65596501 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 1.55610089 |
| 21 | MP0005408_hypopigmentation | 1.33310582 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.20600204 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.12171531 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.10711878 |
| 25 | MP0003011_delayed_dark_adaptation | 1.06424420 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.97755046 |
| 27 | MP0005636_abnormal_mineral_homeostasis | 0.93590191 |
| 28 | MP0000598_abnormal_liver_morphology | 0.89958475 |
| 29 | MP0009053_abnormal_anal_canal | 0.88339144 |
| 30 | MP0003186_abnormal_redox_activity | 0.87635271 |
| 31 | MP0001661_extended_life_span | 0.86392161 |
| 32 | MP0008872_abnormal_physiological_respon | 0.86261862 |
| 33 | MP0005187_abnormal_penis_morphology | 0.83946053 |
| 34 | MP0009642_abnormal_blood_homeostasis | 0.83862296 |
| 35 | MP0010368_abnormal_lymphatic_system | 0.77130939 |
| 36 | MP0008469_abnormal_protein_level | 0.74674226 |
| 37 | MP0002132_abnormal_respiratory_system | 0.74514875 |
| 38 | MP0005376_homeostasis/metabolism_phenot | 0.73694950 |
| 39 | MP0003638_abnormal_response/metabolism_ | 0.72353836 |
| 40 | MP0005395_other_phenotype | 0.72012855 |
| 41 | MP0000604_amyloidosis | 0.71214616 |
| 42 | MP0003879_abnormal_hair_cell | 0.71155934 |
| 43 | MP0003656_abnormal_erythrocyte_physiolo | 0.71076641 |
| 44 | MP0005535_abnormal_body_temperature | 0.66372077 |
| 45 | MP0005670_abnormal_white_adipose | 0.65266934 |
| 46 | MP0009764_decreased_sensitivity_to | 0.63734475 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 0.62731399 |
| 48 | MP0010386_abnormal_urinary_bladder | 0.61998385 |
| 49 | MP0002971_abnormal_brown_adipose | 0.59291455 |
| 50 | MP0009763_increased_sensitivity_to | 0.58995367 |
| 51 | MP0002168_other_aberrant_phenotype | 0.57548071 |
| 52 | MP0002282_abnormal_trachea_morphology | 0.54819574 |
| 53 | MP0003959_abnormal_lean_body | 0.53827318 |
| 54 | MP0006036_abnormal_mitochondrial_physio | 0.52972651 |
| 55 | MP0000566_synostosis | 0.52249224 |
| 56 | MP0005266_abnormal_metabolism | 0.50797798 |
| 57 | MP0002928_abnormal_bile_duct | 0.50605027 |
| 58 | MP0005448_abnormal_energy_balance | 0.49618107 |
| 59 | MP0003718_maternal_effect | 0.48754526 |
| 60 | MP0004043_abnormal_pH_regulation | 0.48612531 |
| 61 | MP0004142_abnormal_muscle_tone | 0.48323664 |
| 62 | MP0005451_abnormal_body_composition | 0.47633043 |
| 63 | MP0005084_abnormal_gallbladder_morpholo | 0.47198553 |
| 64 | MP0005220_abnormal_exocrine_pancreas | 0.44696755 |
| 65 | MP0001756_abnormal_urination | 0.43329440 |
| 66 | MP0005334_abnormal_fat_pad | 0.43128767 |
| 67 | MP0003953_abnormal_hormone_level | 0.40681620 |
| 68 | MP0002136_abnormal_kidney_physiology | 0.39705818 |
| 69 | MP0003690_abnormal_glial_cell | 0.39553946 |
| 70 | MP0005464_abnormal_platelet_physiology | 0.39172032 |
| 71 | MP0008874_decreased_physiological_sensi | 0.38919683 |
| 72 | MP0005647_abnormal_sex_gland | 0.35848971 |
| 73 | MP0001915_intracranial_hemorrhage | 0.35556234 |
| 74 | MP0005551_abnormal_eye_electrophysiolog | 0.35379940 |
| 75 | MP0001944_abnormal_pancreas_morphology | 0.32439989 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.32100696 |
| 77 | MP0003878_abnormal_ear_physiology | 0.31137235 |
| 78 | MP0005377_hearing/vestibular/ear_phenot | 0.31137235 |
| 79 | MP0002909_abnormal_adrenal_gland | 0.30993401 |
| 80 | MP0004130_abnormal_muscle_cell | 0.29920789 |
| 81 | MP0000249_abnormal_blood_vessel | 0.29776017 |
| 82 | MP0001440_abnormal_grooming_behavior | 0.29387867 |
| 83 | MP0009785_altered_susceptibility_to | 0.29286694 |
| 84 | MP0001986_abnormal_taste_sensitivity | 0.28011504 |
| 85 | MP0005645_abnormal_hypothalamus_physiol | 0.27659531 |
| 86 | MP0001663_abnormal_digestive_system | 0.27544453 |
| 87 | MP0002090_abnormal_vision | 0.25481906 |
| 88 | MP0005164_abnormal_response_to | 0.24824494 |
| 89 | MP0003183_abnormal_peptide_metabolism | 0.24084704 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 0.23920087 |
| 91 | MP0003632_abnormal_nervous_system | 0.23331744 |
| 92 | MP0005166_decreased_susceptibility_to | 0.22231133 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.21128223 |
| 94 | MP0005646_abnormal_pituitary_gland | 0.21005077 |
| 95 | MP0004924_abnormal_behavior | 0.20548096 |
| 96 | MP0005386_behavior/neurological_phenoty | 0.20548096 |
| 97 | MP0005023_abnormal_wound_healing | 0.19888623 |
| 98 | MP0004883_abnormal_blood_vessel | 0.19631066 |
| 99 | MP0001845_abnormal_inflammatory_respons | 0.19323168 |
| 100 | MP0002069_abnormal_eating/drinking_beha | 0.18172782 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.03015959 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 7.95507586 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 7.85784153 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.78246321 |
| 5 | Complement deficiency (HP:0004431) | 7.76071673 |
| 6 | Conjugated hyperbilirubinemia (HP:0002908) | 7.09162969 |
| 7 | Abnormality of complement system (HP:0005339) | 6.22410894 |
| 8 | Systemic lupus erythematosus (HP:0002725) | 5.51205165 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 5.46975576 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 5.14437679 |
| 11 | Joint hemorrhage (HP:0005261) | 5.00384878 |
| 12 | Glomerulonephritis (HP:0000099) | 4.91663464 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.73649587 |
| 14 | Xanthomatosis (HP:0000991) | 4.70648020 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.46090775 |
| 16 | Fat malabsorption (HP:0002630) | 4.43779266 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.32863098 |
| 18 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.31515195 |
| 19 | Spontaneous abortion (HP:0005268) | 3.99343640 |
| 20 | Hyperglycinemia (HP:0002154) | 3.94347916 |
| 21 | Generalized aminoaciduria (HP:0002909) | 3.83880994 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.78193727 |
| 23 | Steatorrhea (HP:0002570) | 3.73683607 |
| 24 | Nephritis (HP:0000123) | 3.70571239 |
| 25 | Hyperammonemia (HP:0001987) | 3.58572357 |
| 26 | Rickets (HP:0002748) | 3.45304819 |
| 27 | Abnormality of glycine metabolism (HP:0010895) | 3.42443400 |
| 28 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.42443400 |
| 29 | Hyperglycinuria (HP:0003108) | 3.31737465 |
| 30 | Delayed CNS myelination (HP:0002188) | 3.27179498 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.23997710 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.21172027 |
| 33 | Vascular calcification (HP:0004934) | 3.19432288 |
| 34 | Abnormality of serum amino acid levels (HP:0003112) | 3.08071946 |
| 35 | Abnormality of urine glucose concentration (HP:0011016) | 2.97804654 |
| 36 | Glycosuria (HP:0003076) | 2.97804654 |
| 37 | Abnormality of vitamin metabolism (HP:0100508) | 2.92295521 |
| 38 | Osteomalacia (HP:0002749) | 2.91547173 |
| 39 | Mitral stenosis (HP:0001718) | 2.78099424 |
| 40 | Cardiovascular calcification (HP:0011915) | 2.77730355 |
| 41 | Hyperphosphaturia (HP:0003109) | 2.76961271 |
| 42 | Fair hair (HP:0002286) | 2.75867947 |
| 43 | Epidermoid cyst (HP:0200040) | 2.74276255 |
| 44 | Abnormality of methionine metabolism (HP:0010901) | 2.71802926 |
| 45 | Hyperbilirubinemia (HP:0002904) | 2.65902501 |
| 46 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.62555822 |
| 47 | Hemorrhage of the eye (HP:0011885) | 2.62497953 |
| 48 | Gingival bleeding (HP:0000225) | 2.61938169 |
| 49 | Abnormality of nucleobase metabolism (HP:0010932) | 2.61197740 |
| 50 | Reduced antithrombin III activity (HP:0001976) | 2.59070158 |
| 51 | Hypercholesterolemia (HP:0003124) | 2.58070389 |
| 52 | Metabolic acidosis (HP:0001942) | 2.53935432 |
| 53 | Hydroxyprolinuria (HP:0003080) | 2.49287304 |
| 54 | Abnormality of proline metabolism (HP:0010907) | 2.49287304 |
| 55 | Ketosis (HP:0001946) | 2.32418120 |
| 56 | Hypoalphalipoproteinemia (HP:0003233) | 2.26440218 |
| 57 | Irritability (HP:0000737) | 2.25413304 |
| 58 | Abnormal urine phosphate concentration (HP:0012599) | 2.24000524 |
| 59 | Arthropathy (HP:0003040) | 2.22526351 |
| 60 | Alkalosis (HP:0001948) | 2.21182194 |
| 61 | Bifid scrotum (HP:0000048) | 2.20456770 |
| 62 | Neonatal hypoglycemia (HP:0001998) | 2.19835168 |
| 63 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.19765815 |
| 64 | Purpura (HP:0000979) | 2.15042613 |
| 65 | Thrombophlebitis (HP:0004418) | 2.13503199 |
| 66 | Abnormal biliary tract physiology (HP:0012439) | 2.11298218 |
| 67 | Bile duct proliferation (HP:0001408) | 2.11298218 |
| 68 | Pulmonary embolism (HP:0002204) | 2.09051488 |
| 69 | Hepatocellular carcinoma (HP:0001402) | 2.05958534 |
| 70 | Lethargy (HP:0001254) | 2.02963152 |
| 71 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.0795186 |
| 72 | Hypophosphatemic rickets (HP:0004912) | 1.99160150 |
| 73 | Generalized hypopigmentation of hair (HP:0011358) | 1.98937695 |
| 74 | Hypochromic microcytic anemia (HP:0004840) | 1.95733202 |
| 75 | Hypoglycemic coma (HP:0001325) | 1.92440392 |
| 76 | Cerebral edema (HP:0002181) | 1.89707668 |
| 77 | Proximal tubulopathy (HP:0000114) | 1.89509279 |
| 78 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.87759159 |
| 79 | Poikilocytosis (HP:0004447) | 1.87052669 |
| 80 | Abnormality of purine metabolism (HP:0004352) | 1.83135573 |
| 81 | Elevated alkaline phosphatase (HP:0003155) | 1.82114226 |
| 82 | Joint swelling (HP:0001386) | 1.82042933 |
| 83 | Azoospermia (HP:0000027) | 1.77724051 |
| 84 | Menorrhagia (HP:0000132) | 1.77152469 |
| 85 | Pancreatitis (HP:0001733) | 1.76838298 |
| 86 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.76761777 |
| 87 | Ketoacidosis (HP:0001993) | 1.76516294 |
| 88 | Cerebral palsy (HP:0100021) | 1.72948840 |
| 89 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.72184089 |
| 90 | Abnormality of iron homeostasis (HP:0011031) | 1.70934684 |
| 91 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.70472165 |
| 92 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.70429142 |
| 93 | Sensorimotor neuropathy (HP:0007141) | 1.69011484 |
| 94 | Abnormality of the Achilles tendon (HP:0005109) | 1.66957955 |
| 95 | Enlarged kidneys (HP:0000105) | 1.64979280 |
| 96 | Cholelithiasis (HP:0001081) | 1.59800217 |
| 97 | Abnormal gallbladder morphology (HP:0012437) | 1.58883623 |
| 98 | Facial shape deformation (HP:0011334) | 1.57339086 |
| 99 | Potter facies (HP:0002009) | 1.57339086 |
| 100 | Vomiting (HP:0002013) | 1.56732510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.62703607 |
| 2 | LMTK2 | 3.40405925 |
| 3 | PIK3CA | 3.11448631 |
| 4 | ACVR1B | 2.99969986 |
| 5 | PIK3CG | 2.68533425 |
| 6 | INSRR | 2.57322792 |
| 7 | GRK1 | 2.56634124 |
| 8 | ADRBK2 | 2.53012275 |
| 9 | ERN1 | 2.52872161 |
| 10 | CASK | 2.40342084 |
| 11 | PINK1 | 2.39230769 |
| 12 | MAP3K12 | 2.10327258 |
| 13 | NTRK3 | 2.02541692 |
| 14 | MST1R | 1.93513887 |
| 15 | PRKCG | 1.89994629 |
| 16 | PRKACG | 1.89009179 |
| 17 | WNK3 | 1.81565557 |
| 18 | PRKAA2 | 1.69007118 |
| 19 | CAMKK2 | 1.66871968 |
| 20 | FGFR4 | 1.59517480 |
| 21 | BMPR1B | 1.50756800 |
| 22 | BCKDK | 1.45489802 |
| 23 | EPHA3 | 1.42488600 |
| 24 | TYK2 | 1.39713153 |
| 25 | PNCK | 1.38801306 |
| 26 | MAP2K4 | 1.38340598 |
| 27 | EPHA4 | 1.31924577 |
| 28 | FER | 1.31522697 |
| 29 | MAP3K2 | 1.30125432 |
| 30 | PRKG2 | 1.27258827 |
| 31 | PRKCZ | 1.23141820 |
| 32 | DAPK2 | 1.22464025 |
| 33 | NLK | 1.19043550 |
| 34 | TAOK3 | 1.17554362 |
| 35 | WNK4 | 1.15108043 |
| 36 | IGF1R | 1.13546446 |
| 37 | ABL2 | 1.12554968 |
| 38 | PAK3 | 1.10954359 |
| 39 | STK38L | 1.10014196 |
| 40 | ERBB2 | 1.08531814 |
| 41 | MAPKAPK3 | 1.08157466 |
| 42 | STK39 | 1.05847397 |
| 43 | MAPK11 | 1.03118309 |
| 44 | TBK1 | 1.01664002 |
| 45 | RIPK1 | 1.00577359 |
| 46 | MYLK | 0.99473902 |
| 47 | AKT3 | 0.99187638 |
| 48 | OXSR1 | 0.97557683 |
| 49 | MAP3K3 | 0.95745610 |
| 50 | NEK9 | 0.95591414 |
| 51 | PRKACA | 0.93308881 |
| 52 | FGFR3 | 0.93292608 |
| 53 | MUSK | 0.92190457 |
| 54 | PRKCE | 0.90053538 |
| 55 | SIK1 | 0.88293643 |
| 56 | TNK2 | 0.87717668 |
| 57 | PRKAA1 | 0.87028946 |
| 58 | PRKG1 | 0.84440074 |
| 59 | PRKCA | 0.81709844 |
| 60 | TIE1 | 0.80200663 |
| 61 | MET | 0.79639521 |
| 62 | TNIK | 0.76132841 |
| 63 | STK16 | 0.73217189 |
| 64 | BCR | 0.71664019 |
| 65 | PTK6 | 0.66004449 |
| 66 | CSNK1D | 0.65124496 |
| 67 | PRKCQ | 0.64430794 |
| 68 | BRSK2 | 0.63180790 |
| 69 | IRAK1 | 0.62450474 |
| 70 | MAPK15 | 0.62146492 |
| 71 | FGFR2 | 0.60927710 |
| 72 | CAMK1D | 0.60927289 |
| 73 | PDPK1 | 0.60280421 |
| 74 | TLK1 | 0.59013993 |
| 75 | MAP2K7 | 0.58365813 |
| 76 | DYRK2 | 0.56959237 |
| 77 | SGK223 | 0.56860345 |
| 78 | SGK494 | 0.56860345 |
| 79 | MAPK13 | 0.55629781 |
| 80 | MAP2K6 | 0.54907738 |
| 81 | SGK2 | 0.53778818 |
| 82 | ERBB4 | 0.53492539 |
| 83 | PRKCB | 0.53053178 |
| 84 | MAP3K4 | 0.51354967 |
| 85 | JAK2 | 0.49309269 |
| 86 | STK38 | 0.49135321 |
| 87 | CSNK1A1 | 0.48346361 |
| 88 | CAMK1G | 0.46470643 |
| 89 | CSNK1E | 0.45961016 |
| 90 | MAP2K2 | 0.45743667 |
| 91 | MAP3K11 | 0.44091575 |
| 92 | MAP3K1 | 0.43638978 |
| 93 | SGK1 | 0.43462893 |
| 94 | MAP2K1 | 0.43100921 |
| 95 | RPS6KA3 | 0.42581509 |
| 96 | JAK1 | 0.41832099 |
| 97 | ADRBK1 | 0.41207424 |
| 98 | RET | 0.36596030 |
| 99 | PRKACB | 0.36390096 |
| 100 | PDK1 | 0.34961059 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.61047040 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.01225065 |
| 3 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.81729840 |
| 4 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.42413547 |
| 5 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.41370248 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.31620287 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.19168805 |
| 8 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 3.00534730 |
| 9 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.00459181 |
| 10 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.91700984 |
| 11 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.80041477 |
| 12 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.69536221 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.41646506 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.38723314 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.36534135 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.27105941 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.16309603 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.07111669 |
| 19 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.01029806 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.96691315 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.96188237 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.96158407 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89860459 |
| 24 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.82226772 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.66589179 |
| 26 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.66462182 |
| 27 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.65722389 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.46177384 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.44019582 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.37824052 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.36359263 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.33055308 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.18010979 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17235502 |
| 35 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.16906460 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.11502752 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.09070342 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.05524956 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05328253 |
| 40 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.05211646 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.04482521 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99759739 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98976852 |
| 44 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95315600 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.95073193 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.94706311 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80832000 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.79792960 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76670153 |
| 50 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76599116 |
| 51 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.75434368 |
| 52 | Carbon metabolism_Homo sapiens_hsa01200 | 0.69134289 |
| 53 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65910992 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64709922 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.60769455 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60243723 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53391454 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.50637792 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.50143615 |
| 60 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.46867376 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46475503 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.40744926 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.33528576 |
| 64 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.30173101 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24130896 |
| 66 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.22016969 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.19347934 |
| 68 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.18967983 |
| 69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17586443 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.17170848 |
| 71 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14981028 |
| 72 | Pertussis_Homo sapiens_hsa05133 | 0.12999743 |
| 73 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.11918088 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.10533038 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.10369961 |
| 76 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.10223679 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.08267459 |
| 78 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.07101358 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.05020402 |
| 80 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.04369493 |
| 81 | Galactose metabolism_Homo sapiens_hsa00052 | 0.00962265 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.00175729 |
| 83 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2132159 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2037554 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1767155 |
| 86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.1686777 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1679214 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1663584 |
| 89 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1517570 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1419943 |
| 91 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.1419287 |
| 92 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.1396494 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1174512 |
| 94 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1050973 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.1027800 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.0676163 |
| 97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0293337 |
| 98 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0184774 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.0115989 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | -0.0114026 |

